glp 1 drugs and muscle loss Weight-Loss Medications, Joint Pain, Bone Health: What Patients Need to Know GLP-1 and Muscle Loss: Semaglutide,

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

GLP-1 medications and low blood pressure: Learn how semaglutide, tirzepatide, and other GLP-1 drugs affect blood pressure, recognize hypotension symptoms, and discover essential management strategies to stay safe during treatment.

Clinical Frameworks: Defining Obesity Beyond Body Mass Index (BMI) An important milestone of 2025 was the publication of The Lancet Diabetes & Endocrinology Commission on the Definition and Diagnostic Criteria of Clinical Obesity

Connect with certified providers on Meto for personalized support and results

The aim of this literature review is to discuss evidence from basic science, human studies, and clinical trials to support the preferential use of GLP-1 RAs in asthma patients with co-occurring diabetes and obesity